News | Press Releases

For Immediate Release Contact marketingcommunications@us.medical.canon

August 7, 2014

Toshiba’s New Technology Enables Blood Flow Visualization Never Thought Possible with Ultrasound

 

(Left) Image of Hepatic Vein using Color Doppler; (Right): ) Image using color mode of SMI (cSMI) showing the detail resolution and numerous microvessels of the liver at high frame rates.

(Left) Image of Hepatic Vein using Color Doppler; (Right): ) Image using color mode of SMI (cSMI) showing the detail resolution and numerous microvessels of the liver at high frame rates.

Superb Micro-Vascular Imaging Helps Clinicians Deliver a More Accurate Diagnosis

Lake Buena Vista, Fla., Aug. 7, 2014 –Toshiba is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose disease faster and non-invasively.

Currently, physicians wanting to see low-velocity microvascular blood flow have to use contrast agents or more invasive modalities. Superb Micro-Vascular Imaging (SMI) can dramatically improve the patient’s overall imaging experience by making exams safer and faster, getting them the diagnostic information needed.

SMI has received FDA clearance for use on the AplioTM 500 ultrasound system and will be showcased at the Society of Vascular Ultrasound (SVU) Annual Conference, August 6–9, 2014 (Booth #214) in Lake Buena Vista, Fl.

“Toshiba ultrasound continues to push the envelope,” said Tomohiro Hasegawa, director, Ultrasound Business Unit. “With the development of SMI, clinicians can provide the right diagnosis on all patients earlier for improved care. Additionally, SMI expands the utility of ultrasound, which results in fewer ionizing procedures, improving patient safety.”

Diagnostic and Interventional Cardiology recognized SMI as Editor’s Choice of Most Innovative Technology at ASE 2014: http://www.dicardiology.net/view-all/videos/?bclid=922766709001&bctid=3657051609001.

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical product and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society. Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.